The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway
about
Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicinPromising Druggable Target in Head and Neck Squamous Cell Carcinoma: Wnt SignalingFrizzled homolog proteins, microRNAs and Wnt signaling in cancerFZD1 regulates cumulus expansion genes and is required for normal female fertility in mice.FH535 Suppresses Osteosarcoma Growth In Vitro and Inhibits Wnt Signaling through TankyrasesLRP6 overexpression defines a class of breast cancer subtype and is a target for therapy.The cross-talk between canonical and non-canonical Wnt-dependent pathways regulates P-glycoprotein expression in human blood-brain barrier cells.Nuclear localizaiton of β-catenin is associated with poor survival and chemo-/radioresistance in human cervical squamous cell cancer.Wnt/β-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia.Evidence of a role for activation of Wnt/beta-catenin signaling in the resistance of plasma cells to lenalidomide.An Introspective Update on the Influence of miRNAs in Breast Carcinoma and Neuroblastoma ChemoresistanceWnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathwaySETDB1 accelerates tumourigenesis by regulating the WNT signalling pathway.Functional sphere profiling reveals the complexity of neuroblastoma tumor-initiating cell model.Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapy.Multiple signatures of a disease in potential biomarker space: Getting the signatures consensus and identification of novel biomarkers.PPP1R12A Copy Number Is Associated with Clinical Outcomes of Stage III CRC Receiving Oxaliplatin-Based ChemotherapyOverexpression of β-Catenin Induces Cisplatin Resistance in Oral Squamous Cell Carcinoma.Reversible adaptive plasticity: a mechanism for neuroblastoma cell heterogeneity and chemo-resistanceRetinoid X receptor α enhances human cholangiocarcinoma growth through simultaneous activation of Wnt/β-catenin and nuclear factor-κB pathwaysMechanisms of chemoresistance in cancer stem cells.Frizzled-1 receptor regulates adult hippocampal neurogenesis.Modulation of the Wnt/beta-catenin pathway in human oligodendroglioma cells by Sox17 regulates proliferation and differentiationOncogenic activity of retinoic acid receptor γ is exhibited through activation of the Akt/NF-κB and Wnt/β-catenin pathways in cholangiocarcinoma.Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progressionHuman Breast Cancer Stem Cells Have Significantly Higher Rate of Clathrin-Independent and Caveolin-Independent Endocytosis than the Differentiated Breast Cancer Cells.Targeting XBP1-mediated β-catenin expression associated with bladder cancer with newly synthetic Oridonin analogues.Apoptotic cell death in neuroblastoma.ABCB1 and ABCG2 drug transporters are differentially expressed in non-small cell lung cancers (NSCLC) and expression is modified by cisplatin treatment via altered Wnt signaling.Overcoming multidrug resistance in human cancer cells by natural compoundsβ-Catenin Signalling in Glioblastoma Multiforme and Glioma-Initiating CellsInvasive colon cancer, but not non-invasive adenomas induce a gradient effect of Wnt pathway receptor frizzled 1 (Fz1) expression in the tumor microenvironment.Roles of Wnt Target Genes in the Journey of Cancer Stem CellsWnt/β-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance.miR-33a suppresses the nuclear translocation of β-catenin to enhance gemcitabine sensitivity in human pancreatic cancer cells.Silencing dishevelled-1 sensitizes paclitaxel-resistant human ovarian cancer cells via AKT/GSK-3β/β-catenin signalling.Cancer stem-like cells from head and neck cancers are chemosensitized by the Wnt antagonist, sFRP4, by inducing apoptosis, decreasing stemness, drug resistance and epithelial to mesenchymal transition.Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling.Array analysis for potential biomarker of gemcitabine identification in non-small cell lung cancer cell lines.Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia.
P2860
Q24292953-3F884A03-FE71-4DC3-9D94-946523485336Q26738491-49F09A93-13E4-4500-B3BA-A2DD884145E4Q27010132-A99E5EFF-00B9-42F7-B11A-C9CF9B6F7E29Q30416497-76754C3C-5135-4284-9960-9836E55B8164Q33715651-9AC0CCFE-B799-45BB-B634-E4126D671C51Q33740256-A58F7A2A-5A55-450E-99CB-41ED36EBBD4BQ34018635-40E70621-49D3-4C8E-ADB9-660545AAE0AEQ34029022-ACF806BC-FF63-4D05-832C-D5689046B7FBQ34348134-6A2FF075-3C6D-46A2-9C5B-2BC4A88F5286Q34719436-61D25678-4BFC-4322-8C5A-FAEA75C75084Q34753903-E1D634C6-4E12-445B-9383-448E7181CF08Q35067970-70E92F06-BE42-4FA4-A891-B21291342262Q35097426-38B14543-E60C-47D6-A714-58E79FEDB028Q35444381-51EC4804-B5F0-4DAA-AAF1-6C81AB1E0FECQ35661951-49DE4B43-2540-4A69-888E-A61914C49252Q35671355-3B18E032-27A9-4653-A84B-905D043C6018Q35737787-7885208B-BC3F-4CA4-BB0E-2C92DEC323B3Q36104764-9747C1A2-69B6-4938-A331-10DDD008F3A6Q36144256-792EF216-8EA1-4BE3-B059-D29A9A8142DCQ36467491-D3BC32EC-6B25-4B64-87B4-EB22F1A11313Q36591484-EA0FBC4A-28DD-48EB-8BB5-31E258721F2EQ36686869-8ECED2EE-B615-48DA-BC80-CBDF217BA5D9Q36893363-D1E74236-6FE9-4B46-98E7-ACD009007A59Q37122721-97B07D60-8AE4-46D3-BFC2-AA302BE3FA2BQ37225412-190E234F-75DF-41B1-A386-BF1237154EC0Q37368287-019BAD97-1FCD-432A-9C46-FD1859CD0ED9Q37636708-8D9C466A-548C-4B0D-A440-36CBDB53E9A5Q37679253-91FCAA53-71CD-4607-8CEB-78C1B1570E76Q37719572-B644A425-AC7E-4837-B948-9D1FF75F5000Q37954295-0FE15696-CF17-4247-8880-D9EE88CD45E4Q37991708-0915F683-2EDA-4599-8007-7B2B46BD5078Q38084793-E747A659-8B55-4DDD-901B-9DFC4C3668B8Q38557075-EC00538B-3C84-45F9-BCD6-114255FBEEDFQ38807957-1C239801-42CC-4158-A90B-2A82A73F322FQ38859854-80A47756-A549-4CAD-9DB4-7539E523E29BQ38913984-8F5B49BE-7B35-41E5-B94A-50B87A5B4DC3Q38967885-8C8F0CF2-34ED-4ACE-B492-F57F9228630DQ39027411-A331E5F6-F8F7-40FB-B1FE-21CEB366927EQ39095223-6CABC8AA-7A28-4446-8A46-E421768B2E52Q39118557-6EED8BAB-5BCD-457C-9044-05C2C22BA6A1
P2860
The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The Wnt receptor FZD1 mediates ...... f the Wnt/beta-catenin pathway
@ast
The Wnt receptor FZD1 mediates ...... f the Wnt/beta-catenin pathway
@en
The Wnt receptor FZD1 mediates ...... f the Wnt/beta-catenin pathway
@en-gb
The Wnt receptor FZD1 mediates ...... f the Wnt/beta-catenin pathway
@nl
type
label
The Wnt receptor FZD1 mediates ...... f the Wnt/beta-catenin pathway
@ast
The Wnt receptor FZD1 mediates ...... f the Wnt/beta-catenin pathway
@en
The Wnt receptor FZD1 mediates ...... f the Wnt/beta-catenin pathway
@en-gb
The Wnt receptor FZD1 mediates ...... f the Wnt/beta-catenin pathway
@nl
prefLabel
The Wnt receptor FZD1 mediates ...... f the Wnt/beta-catenin pathway
@ast
The Wnt receptor FZD1 mediates ...... f the Wnt/beta-catenin pathway
@en
The Wnt receptor FZD1 mediates ...... f the Wnt/beta-catenin pathway
@en-gb
The Wnt receptor FZD1 mediates ...... f the Wnt/beta-catenin pathway
@nl
P2093
P2860
P3181
P356
P1433
P1476
The Wnt receptor FZD1 mediates ...... f the Wnt/beta-catenin pathway
@en
P2093
D Martinet
F K Niggli
J S Beckmann
J-M Joseph
K A Nardou
P2860
P2888
P304
P3181
P356
10.1038/ONC.2009.80
P407
P577
2009-06-11T00:00:00Z
P5875
P6179
1042705033